ESMO-话题@MedSci

#ESMO#

214篇内容 | 5254人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1280896, encodeId=f977128089622, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO：制药巨头研究进展盘点, objectType=article, longId=40983, objectId=21124098352, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21124098352, replyNumber=0, likeNumber=47, createdTime=2014-10-10, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21124098352, moduleTitle=ESMO：制药巨头研究进展盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21124098352)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280894, encodeId=aa52128089476, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2014：抗PD-L1联合贝伐单抗用于肾透明细胞癌安全和效果良好, objectType=article, longId=40875, objectId=3d03408e567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d03408e567, replyNumber=0, likeNumber=78, createdTime=2014-10-04, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d03408e567, moduleTitle=ESMO 2014：抗PD-L1联合贝伐单抗用于肾透明细胞癌安全和效果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d03408e567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280893, encodeId=e9441280893c6, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2014：NSCLC的中国临床研究结果汇报, objectType=article, longId=40874, objectId=49fd408e4c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49fd408e4c0, replyNumber=0, likeNumber=91, createdTime=2014-10-04, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49fd408e4c0, moduleTitle=ESMO 2014：NSCLC的中国临床研究结果汇报, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49fd408e4c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280892, encodeId=ebc81280892e6, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2014：吉西他滨联合顺铂(GP)或紫杉醇(GT)一线治疗复发或转移性三阴性乳腺癌获良好疗效(CBCSG006试验), objectType=article, longId=40873, objectId=e833408e36f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e833408e36f, replyNumber=0, likeNumber=83, createdTime=2014-10-04, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e833408e36f, moduleTitle=ESMO 2014：吉西他滨联合顺铂(GP)或紫杉醇(GT)一线治疗复发或转移性三阴性乳腺癌获良好疗效(CBCSG006试验), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e833408e36f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280891, encodeId=34c91280891bb, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2014：帕妥珠单抗方案能显著提高转移性乳腺癌总生存期（CLEOPATRA研究）, objectType=article, longId=40872, objectId=1489408e2f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1489408e2f5, replyNumber=0, likeNumber=70, createdTime=2014-10-04, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1489408e2f5, moduleTitle=ESMO 2014：帕妥珠单抗方案能显著提高转移性乳腺癌总生存期（CLEOPATRA研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1489408e2f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280890, encodeId=58791280890cb, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO盛会开幕，身在马德里不可错过的6件事, objectType=article, longId=40751, objectId=1c5e40e5120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c5e40e5120, replyNumber=0, likeNumber=85, createdTime=2014-09-30, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c5e40e5120, moduleTitle=ESMO盛会开幕，身在马德里不可错过的6件事, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c5e40e5120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280889, encodeId=241512808899e, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2014：进展期非小细胞肺癌指南, objectType=article, longId=40172, objectId=4cca401e2d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cca401e2d6, replyNumber=0, likeNumber=76, createdTime=2014-09-13, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cca401e2d6, moduleTitle=ESMO 2014：进展期非小细胞肺癌指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cca401e2d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280888, encodeId=345e128088853, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2014 ：肛管鳞癌临床实践指南解读, objectType=article, longId=39890, objectId=f25c398905e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f25c398905e, replyNumber=0, likeNumber=72, createdTime=2014-09-05, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f25c398905e, moduleTitle=ESMO 2014 ：肛管鳞癌临床实践指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f25c398905e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280887, encodeId=8f6b128088ef7, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO：新肿瘤患者骨健康临床实践指南, objectType=article, longId=34661, objectId=dd22346617d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd22346617d, replyNumber=0, likeNumber=79, createdTime=2014-05-15, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd22346617d, moduleTitle=ESMO：新肿瘤患者骨健康临床实践指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd22346617d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280886, encodeId=dce11280886e8, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）, objectType=article, longId=27180, objectId=0e472e180a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e472e180a3, replyNumber=0, likeNumber=92, createdTime=2013-11-29, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e472e180a3, moduleTitle=ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e472e180a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280885, encodeId=8208128088566, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO 2013：FIRE-3研究新数据解读, objectType=article, longId=26761, objectId=d7d526e61d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d526e61d5, replyNumber=0, likeNumber=0, createdTime=2013-11-21, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d526e61d5, moduleTitle=ESMO 2013：FIRE-3研究新数据解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d526e61d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280884, encodeId=67271280884ad, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO年会：来那度胺治疗晚期前列腺癌生存率低, objectType=article, longId=10379, objectId=3aef103e954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aef103e954, replyNumber=0, likeNumber=68, createdTime=2012-10-14, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aef103e954, moduleTitle=ESMO年会：来那度胺治疗晚期前列腺癌生存率低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aef103e954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280883, encodeId=7e08128088317, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO年会：抗肾细胞癌疫苗研究取得进展, objectType=article, longId=10100, objectId=570a1010092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=570a1010092, replyNumber=0, likeNumber=71, createdTime=2012-10-10, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=570a1010092, moduleTitle=ESMO年会：抗肾细胞癌疫苗研究取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=570a1010092)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280882, encodeId=569b128088223, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2012 ESMO临床实践指南：结直肠癌, objectType=article, longId=10047, objectId=eb151004e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb151004e9e, replyNumber=0, likeNumber=92, createdTime=2012-10-04, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb151004e9e, moduleTitle=2012 ESMO临床实践指南：结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb151004e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280881, encodeId=d06b1280881a0, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=第35届欧洲肿瘤内科学会（ESMO）大会纪要, objectType=article, longId=2249, objectId=029c2249e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=029c2249e5, replyNumber=0, likeNumber=91, createdTime=2010-11-28, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=029c2249e5, moduleTitle=第35届欧洲肿瘤内科学会（ESMO）大会纪要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=029c2249e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280880, encodeId=2bbd128088095, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESMO：一些重要癌症研究报告将陆续公布, objectType=article, longId=2192, objectId=35032192c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35032192c2, replyNumber=0, likeNumber=89, createdTime=2010-10-15, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35032192c2, moduleTitle=ESMO：一些重要癌症研究报告将陆续公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35032192c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ESMO

2020-05-29

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO：制药巨头研究进展盘点

2014-10-10

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2014：抗PD-L1联合贝伐单抗用于肾透明细胞癌安全和效果良好

2014-10-04

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2014：NSCLC的中国临床研究结果汇报

2014-10-04

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2014：吉西他滨联合顺铂(GP)或紫杉醇(GT)一线治疗复发或转移性三阴性乳腺癌获良好疗效(CBCSG006试验)

2014-10-04

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2014：帕妥珠单抗方案能显著提高转移性乳腺癌总生存期（CLEOPATRA研究）

2014-10-04

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO盛会开幕，身在马德里不可错过的6件事

2014-09-30

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2014：进展期非小细胞肺癌指南

2014-09-13

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2014 ：肛管鳞癌临床实践指南解读

2014-09-05

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO：新肿瘤患者骨健康临床实践指南

2014-05-15

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）

2013-11-29

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO 2013：FIRE-3研究新数据解读

2013-11-21

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO年会：来那度胺治疗晚期前列腺癌生存率低

2012-10-14

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO年会：抗肾细胞癌疫苗研究取得进展

2012-10-10

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2012 ESMO临床实践指南：结直肠癌

2012-10-04

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

第35届欧洲肿瘤内科学会（ESMO）大会纪要

2010-11-28

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESMO：一些重要癌症研究报告将陆续公布

2010-10-15

科室
- - 订阅+
  - 更多科室
工具
服务